News | January 07, 2024
Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Medway setup a state-of-the-art Heart Institute in Chennai
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
US FDA approval based on NEURO-TTRansform Phase III results
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Subscribe To Our Newsletter & Stay Updated
